2025. Use of Brexucabtagene Autoleucel in the treatment of Relapsed/refractory Mantle Cell Lymphoma. Electronic Journal Collection Health. 25, 6 (Jun. 2025), e20837. DOI:https://doi.org/10.25248/reas.e20837.2025.